Ketamine vs Esketamine: Critical Differences Explained
In recent years, media reports touting ketamine as a fast-acting, highly effective treatment for severe depression have increased. In part, this phenomenon is due to the US Food and Drug Administration’s (FDA’s) 2019 approval of ketamine’s cousin, esketamine (Spravato), the first antidepressant in a new drug class for treatment-resistant depression (TRD). Yet, news coverage of …
Ketamine vs Esketamine: Critical Differences Explained Read More »